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Background: High blood pressure levels have been associated with elevated atherogenic blood lipid fraction, but
epidemiological surveys often give inconsistent results across population sub-groups. To determine the extent to
which there are differences in lipid profile based on blood pressure levels, we assessed lipid profile of subjects with
high-normal blood pressure and compared with those of hypertensives and optimally normal blood pressure.
Methods: The study was a cross–sectional comparative study conducted at Aminu Kano Teaching Hospital, Kano,
Nigeria. Fasting lipid levels were examined among randomly selected patients with optimally normal blood pressure
(group 1), high – normal blood pressure (group 2) and those with hypertension (group 3). Optimal blood pressure
was defined as systolic blood pressure (SBP) of < 120 mmHg/or diastolic blood pressure (DBP) of < 80 mmHg; and
high- normal blood pressure as SBP of 130 – 139 mmHg and/or DBP of 85 – 89 mmHg.
Results: A total of 300 subjects were studied, 100 in each group. The mean age of subjects in group 1 was 27.32 ± 8.20
years and 60% were female, while that of group 2 was 34.04 ± 6.25 years, and 53% were female, and that for group 3
was 52.81 ± 13.3 years and 56% were female. The mean total cholesterol (TC) for subjects in group1 (3.96 ± 0.40 mmol/L)
was significantly lower than levels in group2 (4.55 ± 1.01 mmol/L); P = <0.001. Subjects in group 3 (5.20 ± 1.88 mmol/L),
however had statistically significant higher mean TC when compared with group 2; (P = 0.03). The difference between
the groups for low density lipoprotein cholesterol (LDL-C) and triglycerides (TG) followed the same pattern as that of
TC, with statistically significant increasing trend across the blood pressure categories. Levels of high density lipoprotein
cholesterol (HDL-C) were however similar across the three groups (group 2 versus group 1; P = 0.49, group 2 versus
group 3; P = 0.9). Increased TC (>5.2 mmol/L) was absent in group1, but found among 11% of group2 subjects and
40% of those in group 3 (P-value for trend <0.001). Mean fasting plasma glucose (FPG) was 3.8 ± 0.4 mmol/L,
4.7 ± 1.1 mmol/L, 5.1 ± 1.9 mmol/L and for subjects in groups 1, 2 and 3 respectively (p > 0.05 for groups 2 Vs 1 and
p <0.001 for groups 2 Vs 3). The differences in mean body mass index (BMI) between the groups followed a similar
trend as that of FPG. Multivariate logistic regression analysis showed that FPG, TG and BMI were the strongest
predictors of prehypertension [odds ratio (OR) 10.14, 95% CI (confidence interval) 3.63 – 28.33, P = 0.000; OR 5.75,
95% CI 2.20 – 15.05, P = 0.000; and OR 2.03, 95% CI 1.57 – 2.62, P = 0.000 respectively].
Conclusion: The study has shown a significant increase in plasma TC, LDL-C and TG values as blood pressure levels
increased from optimally normal, across high-normal to hypertensive levels. There was a similar trend for FPG and BMI,
demonstrating the central role that blood pressure plays in these metabolic disorders in Nigerians. These findings are
relevant in terms of both prevention and treatment of cardiovascular morbidities and mortality.
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High – normal blood pressure (BP) levels have been
found to be associated more frequently than normal BP
with other cardiovascular disease (CVD) risk factors
such as dyslipidaemia, dysglycaemia, overweight/obesity,
micro-albuminuria and increased circulating levels of
various inflammatory markers such as C-reactive pro-
tein, and homocysteine [1].
The clustering of these CVD risk factors significantly
increases cardiovascular disease, a leading cause of mor-
bidity and mortality [1]. However, dyslipidaemia has
been recognized as a strong and independent risk factor
for CVD [2].
Plasma cholesterol levels vary significantly in various
population groups due to differences in geographical
locations, cultural, economical and social conditions,
dietary habits and genetic make up [2,3].
The relationship between high-normal BP and other
CVD risk factors including plasma lipids has not been
well described in Sub–Sahararan Africans including
Nigerians. In the present study therefore, we studied
plasma lipid levels in patients with high-normal BP com-
pared with hypertensives and those with optimally nor-
mal BP. The results of this study will guide judicious
utilization of the scarce resources available for health
care and other competing needs given that the assay for
plasma lipids is expensive and the subjects with high-
normal BP are not “CVD patients”.
Methods
The study was cross sectional and comparative, carried
out in Aminu Kano Teaching Hospital (AKTH), a
tertiary healthcare institution in Kano State, North-
western Nigeria. The study protocol was approved by
the research ethics committee of AKTH, before the
commencement of the study. The study conformed to
the Declaration of Helsinki on investigations involving
human subjects [4] .The study was explained to the pa-
tients in English and also in the local language (Hausa)
and written consent obtained before enrollment into the
study.
Patient selection
The study population comprised of patients at least 18
years of age, attending the Cardiology and General Out-
patient (GOP) clinics of the Hospital. There were 3 pa-
tient groups.
Group 1 – Subjects with optimally normal blood
pressure who presented to GOP with minor
ailments;
Group 2 – Subjects with high - normal blood pressure
who also presented to the GOP with minor ailments;
andGroup 3 –Hypertensive subjects on treatment and
attending the cardiology clinic (first comparative
group); and
One hundred patients were selected and evaluated in
each group as described below. This sample size was
calculated based on the prevalence of high-normal BP of
16.9% in a community-based study in Edo State, Nigeria,
using a validated formula [5,6]. On each of the clinic
days, and for each of the groups, numbers were allocated
to all patients attending the GOP and a maximum of ten
were selected using simple random sampling method by
balloting. This was repeated weekly until the desired
sample size was attained. Similarly this sampling method
was used to select hundred patients being managed for
hypertension (Group 3) at the Cardiology clinic during
the same period.
Patients already selected previously were excluded if
they visited any of the clinics again for another consul-
tation. Also excluded were subjects less than 18 years of
age, pregnant women and those on drugs known to in-
crease blood pressure like steroids and contraceptive
pills, or to modify the lipids such as statins.
Data generation
Blood pressure was measured using mercury sphygmo-
manometer based on standardized techniques [7].
All participants were fasted overnight for 10 – 12
hours after which venous samples were obtained for
plasma concentrations of total cholesterol (TC) and fast-
ing plasma glucose (FPG). Samples for total cholesterol
were placed in labeled plain universal bottles while those
samples for fasting plasma glucose were placed in fluor-
ide oxalate bottles. They were analyzed in the hospital
Chemical Pathology laboratory using the auto-analyzer
machine (Chiron Diagnostic- Bayer, England). Body mass
index (BMI) was calculated from the weight in kilograms
taken with minimal clothing using a standardized weight
scale and divided by the square height in meters. Height
was taken using stadiometer without shoes or head gear.
Optimal blood pressure was defined as systolic blood
pressure (SBP) of < 120 mmHg and/or diastolic blood
pressure (DBP) of < 80 mmHg; high- normal blood pres-
sure as SBP of 130 – 190 mmHg and/or DBP of 85 – 89
mmHg; while hypertension was defined as SBP of ≥ 140
mmHg and/or DBP of ≥ 90 mmHg, using 2003 World
Health Organization/ International Society of Hyperten-
sion (WHO/ISH) guidelines [8]. Dyslipidaemia was de-
fined as the presence of any of high total cholesterol
(TC) (>5.2 mmol/L), high low- density lipoprotein
cholesterol (LDL-C) (>3.38 mmol/L) or low high-
density lipoprotein cholesterol (HDL- C) (<1.0 mmol/
L in men or if ≤ 1.3 mmol/L in women), and triglyc-
erides (TG) ≥ 1.7 mmol/L, based on the Adult
Table 1 Comparison of the baseline characteristics of the study population
Variable Group 1 Group2 Group3 P-value
Optimal BP High- normal BP Hypertensives
Age (years) 27.32 ± 8.2 34.04 ± 6.25 52.18 ± 13.3 1vs2 (<0.001)*
2vs3 (<0.001)*
SBP (mmHg) 105.62 ± 7.15 135.25 ± 1.85 143.32 ± 14.97 1vs2 (<0.001)*
2vs3 (<0.001)*
DBP (mmHg) 70.26 ± 4.58 86.61 ± 0.94 86.76 ± 9.24 1vs2 (<0.001)*
2vs3(<0.001)*
BMI (Kg/m2) 26.55 ± 2.20 22.75 ± 2.20 26.55 ± 4.17 1vs2 (<0.001)*
2vs3 (0.5)
FPG (mmol/L) 3.76 ± 0.40 4.68 ± 1.09 5.08 ± 1.94 1vs2 (<0.001)*
2vs3 (0.690
Key: *P-value statistically significant; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; FBS, fasting plasma glucose; TC, total
cholesterol. All values are expressed as Mean ± Standard deviation.
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considered to be increased when ≥ 25 Kg/m2 (over-
weight; BMI of 25.0 – 29.9 Kg/m2 and obesity; BMI ≥
30 Kg/m2) [10].
Statistical analysis
Data analysis was done using SPSS version 19.0. Quanti-
tative variables were expressed as means and standard
deviations. Qualitative variables were expressed as per-
centages. The chi-square test or Fisher’s exact test where
applicable were used in comparing proportions, while
Student’s t-test was used to compare means. Logistic re-
gression analysis was used to assess the association of
age, anthropometric and serum parameters to blood
pressure (high-normal BP or optimal BP). A p-value
of ≤0.05 was considered significant.
Results
There were 100 patients in each of the three groups.
The mean age of the subjects in group 1 was 27.32 ± 8.2Table 2 Comparison of means of lipid profiles of subjects wit
Variable Group 1 (Optimal BP) Group 2 high-norm
TC 3.96 ± 0.40 4.55 ± 1.01
HDL-C 1.29 ± 0.54 1.32 ± 0.36
LDL-C 2.07 ± 0.70 2.53 ± 1.12
TG 1.20 ± 0.36 1.50 ± 0.73
Key: *p-value statistically significant; TC; total cholesterol, HDL; high density lipopro
means ± standard deviations.years, for group 2, 34.04 ± 6.25 years and 52.18 ± 13.3
years for group 3. The subjects in group 2 were sig-
nificantly older than those in group 1 (P = < 0.001)
while subjects for group 3 were significantly older
than those in group 2 (P = < 0.001). There was how-
ever no significant statistical differences in gender
distribution between the three groups. (P = 0.3) for
each comparison. The other baseline characteristics
are shown in Table 1.
Plasma lipids for the three groups are presented in
Table 2. There was a clear gradient of plasma lipids con-
centrations rising from subjects with optimally normal
BP, across those with high-normal BP, to the group with
hypertension.
Comparing the proportion of increased TC, high LDL-
C, low HDL-C and high TG, there were statistically sig-
nificant differences between both groups 1 and 2; and
groups 2 and 3 except for HDL-C and TG between
groups 2 and 3 (P = 0.24 and 0.6) . The pattern of dysli-
pidaemia among the three groups is shown in Figure 1.h Optimal BP, high – normal BP and hypertension
al BP) Group 3 (Hypertension) p-value
4.68 ± 0.1.09 1 vs2 (<0.001)*
2 vs3 (0.03)*
1.36 ± 1.26 1 vs2 (0.9)
2 vs3 (0.49)
3.01 ± 1.48 1 vs2 (<0.001)*
2 vs3 (0.01)*
1.72 ± 0.83 1 vs2 (<0.001)*
2 vs3 (0.05)*
tein, LDL; low density lipoprotein, TG; triglycerides. All values are expressed as
Figure 1 Pattern of dyslipidaemia among the study and comparative groups. Key: Blue, Optimal; Red, High- normal; Green, Hypertension.
High TC (>5.2 mmol/L) was found in none of subjects with optimal BP, 11% of subjects with high-normal BP and 41% of hypertensives. Low HDL
(<1.0 mmol/L in men and < 1.2 mmol/L in women) was found in 41% of subjects with optimal BP, 42% of subjects with high-normal BP and 33%
of hypertensives. High LDL (>3.33 mmol/L) was found in 6% of subjects with optimal BP, 17% of subjects with high-normal BP and 30% of
hypertensives. High TG (>1.7 mmol/L) was found in none of subjects with optimal BP, 4% of subjects with high-normal BP, 24% of hypertensives.
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BMI, FPG and TG were predictors of high-normal BP
(see Table 3).
Discussion
The present study assessed plasma lipids among subjects
with high-normal BP, and compared the values with
those among hypertensive subjects and subjects with op-
timally normal BP. There was a clear gradient of plasma
lipids concentrations rising from subjects with optimally
normal BP, across those with high-normal BP, to the
group with hypertension. The present study has shown
that hypertensives had significantly higher mean total
cholesterol (TC) than subjects with high-normal BP,
while subjects with high-normal BP had significantly
higher mean TC than those with optimal BP. This finding
differs from that of Isezuo et al. in Sokoto, Northern
Nigeria where subjects with pre-hypertension were found
to have lower mean TC than the normotensives [11]. It
was however similar but lower than what was reported in
Singapore [12]. The higher mean TC levels observed in
Singapore might be explained by the differences in diet
and lifestyle.Table 3 Determinants of high-normal BP Vs Optimal BP
from a Multivariable logistic regression model
Variable OR 95% CI P- value
Age 1.16 1.08 – 1.25 0.001
BMI 2.06 1.57 – 2.62 0.000
FPG 10.14 3.63 – 28.33 0.000
TG 5.75 2.20 – 15.05 0.000
Key: OR; odds ratio, CI; confidence interval, BMI; body mass index, FPG; fasting
plasma glucose, TG; triglycerides.Low HDL-C was the most common dyslipidaemia
among the groups. Hypertensives had highest mean
HDL-C level, followed by subjects with optimally normal
BP and then subjects with high-normal BP, a trend simi-
lar to what was reported by Lee et al. [12]. The findings
of higher mean HDL-C among hypertensives when com-
pared with normal controls was documented in earlier
studies, in the same region [13,14]. The generally low
HDL-C among the study populations is perhaps the re-
sult of low intake of fresh fruits and vegetables by the in-
habitants [14]. The same reason might also apply in this
study.
The pattern of distribution of mean LDL-C and TG
among the groups was however similar to what was re-
ported by previous authors, in which hypertensives had
significantly higher mean LDL-C and TG than than sub-
jects with high-normal BP, while subjects with high-
normal BP had significantly higher mean LDL-C and TG
than those with optimal BP [11,12,15].
The present study also shows increases in plasma
cholesterol, FPG, and BMI levels as the blood pressure
increased, demonstrating the central role that blood
pressure plays in these metabolic disorders in Nigerians.
Similar to what was obtained by Lee et al. in Singapore,
the present study showed age, BMI , FBG and TG as sig-
nificant predictors for high-normal BP [13]. In addition
to these, Isezuo et al., reported DM, impaired glucose
tolerance and cigarette smoking as significant predictors
of both pre-hypertension and hypertension [12].
These findings are relevant in terms of both pre-
vention and treatment of cardiovascular morbidities and
mortality. In principle, many of the patients we studied
could benefit from the polypill. The use of the “polypill”
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lower cost and increase efficiency and adherence by de-
livering multiple intervention in a single pill, than same
medications prescribed and taken separately. Most poly-
pill contain one to three antihypertensive agents, a statin
and some in addition contain aspirin. This idea has still
not been widely studied and implemented. There are
several challenges to make a successful polypill. Tech-
nically, the agents must be stable when combined, and
there must be no adverse reactions when the medica-
tions are taken together and at same time of the day.
Furthermore, it needs to be produced, marketed and dis-
tributed, and it must be economically viable.Limitations of the study
Although the sample size in the present study was above
the estimated minimum, a larger sample size could have
demonstrated statistically significant differences between
the groups in the BMI and FPG, as was the case in cho-
lesterol levels. Still, the observed trend for the FPG and
BMI is relevant in generating hypotheses.Conclusions
The present study has shown that dyslipidaemia is com-
mon among subjects with high-normal BP. There was a
clear gradient of plasma lipids concentrations rising from
subjects with optimally normal BP, across those with high-
normal BP, to the group with hypertension. There was a
similar trend for FPG and BMI.
This study forms a basis for larger population based
studies to determine plasma lipid profile among subjects
with high- normal BP in this environment. We also re-
commend that individuals with high-normal BP should
be screened for other CVD risk factors and have them
corrected through initiation of lifestyle measures in
order to prevent them developing hypertension and
other complications.
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